News|Articles|October 31, 2024
WCG Meets Enrollment 24 Months Early for Top 5 Pharma’s Decentralized Trial
Author(s)WCG Clinical
A sponsor needed to get their Phase II dermatology study enrollment back on track. The study was underway for 11 months across 32 sites globally with only 20 subjects enrolled to date. With WCG support, enrollment was concluded 24 months ahead of schedule.
Related Content
Trending on Applied Clinical Trials Online
1
ACT Brief: Multimodal AI Systems Architecture, Trust-Based Trial Recruitment, and Big Pharma AI Transformation
2
Tailoring Your FSP Approach: Why One Model Doesn’t Fit Every Trial
3
ACT Brief: Simplifying Trials Through Selective Safety Data, AI-Driven Site Partnerships, and Biopharma Strategic Pivots
4
Beyond Eligibility: Making Trust and Behavioral Readiness Actionable in Clinical Trial Recruitment
5